PATENT CLAIM ANALYSIS

Application Number: 15896420
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "336000"]

Abstract:
The invention herein generally relates to pharmaceutical formulations and methods of treating an overweight or obese subject, and overweight- or obesity-related conditions.

Claim (Index 18):
A method for facilitating and maintaining weight loss in a subject, the method comprising: administering to the subject an amount of fumagillin, fumagillol, or fumagillin ketone, or derivatives thereof, or salts, esters or prodrugs of these, effective to result in weight loss in the subject; and administering a therapeutically effective amount of a weight loss agent to maintain a reduced weight in the subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12504722', '15093953', '14573495', '15484399', '13133060']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8202847883875694
- 35 USC 102 Novelty (BERT): 0.6015355352287269
- Combined Prediction Score: 0.798409863071685
- Mean Citation Score: 447.489908
- Max Citation Score: 585.4035
- Similarity Product: 429.3830714383722

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test